Search

Search Results

• 

  Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica

  F. Muratore, C. Salvarani, P. Macchioni

  18-22

  27-03-2018

  Published: 27 March 2018

  2892

  PDF: 1619
• 

  Diagnosis and diagnostic tests for fibromyalgia (syndrome)

  W. Häuser, F. Wolfe

  194-205

  28-09-2012

  Published: 28 September 2012

  4762

  PDF: 4279
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  Published: 27 March 2018

  2105

  PDF: 1540
• 

  Magnetic resonance imaging as a structural refinement to the American College of Rheumathology clinical classification criteria for knee osteoarthritis

  G.A. Minetti, M. Parodi, S. Banderali, E. Silvestri, G. Garlaschi, M.A. Cimmino

  29-12-2022

  Published: 29 December 2022

  975

  PDF: 614

• Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

  C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

  32-37

  Published:

  1607

  PDF: 727
• 

  Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

  A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

  350-359

  20-12-2012

  Published: 20 December 2012

  3022

  PDF: 2599

• 18FDG-PET and large vessel vasculitis: preliminary data on 25 patients

  M. Bruschi, F. De Leonardis, M. Govoni, M. Roncali, N. Prandini, R. La Corte, L. Feggi, F. Trotta

  212-216

  Published:

  1685

  PDF: 1130

• Neuropsychiatric systemic lupus erythematosus: where are we now?

  M. Govoni, N. Rizzo, G. Castellino, M. Padovan, F. Trotta

  215-225

  Published:

  1155

  PDF: 3153
• 

  Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study

  A.B. Rasheed, M.S. Daoud, F.I. Gorial

  170-174

  21-12-2017

  Published: 21 December 2017

  1717

  PDF: 757
• 

  Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques

  B. Ruaro, A. Sulli, V. Smith, C. Pizzorni, S. Paolino, E. Alessandri, M. Cutolo

  147-155

  21-12-2017

  Published: 21 December 2017

  2196

  PDF: 1103

• Wegener’s granulomatosis: an analysis of 50 patients

  G. Di Comite, G. Bonavida, E. Bozzolo, S. Bozzolo, S. Bianchi, G. Ciboddo, M. Tresoldi, L. Praderio, M.G. Sabbadini

  187-192

  11-04-2005

  Published: 11 April 2005

  808

  PDF: 1509

• Efficacy of Cellfood®’s therapy (deutrosulfazyme) in fibromyalgia

  M.E. Nieddu, L. Menza, F. Baldi, B. Frediani, R. marcolongo

  316-321

  Published:

  2446

  PDF: 1574
• 

  Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

  N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

  07-02-2022

  Published: 7 February 2022

  5637

  PDF: 618

• New classification criteria for rheumatoid arthritis

  C.A. Scirè, R. Caproali

  159-162

  Published:

  1995

  PDF: 8932

• Fibromyalgia syndrome: the pharmacological treatment options

  P. Sarzi- Puttini, R. Torta, F. Marinangeli, G. Biasi, M. Spath, D. Buskila, R.H. Gracely, M.A. Giamberardino, L. Bazzichi, M. Cazzola, M. Di Franco, S. Stisi, F. Salaffi, R. Casale, G. Leardini, R. Gorla, A. Marsico, R. Carignola, L. Altomonte, F. Ceccherelli, G. Cassisi, G. Arioli, A. Alciati, F. Atzeni

  50-58

  Published:

  1664

  PDF: 938

• Study of vitamin D status of rheumatoid arthritis patients Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)

  B. Frediani, M. Rossini, S. Adami, G. Bianchi, O. Di Munno, L. Sinigaglia, M. Antonelli, G. Minisola

  314-318

  Published:

  1416

  PDF: 2028
• 

  Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis

  R. Talotta, F. Rigamonti, T. Letizia, S. Bongiovanni, M.C. Ditto, M. Antivalle, S. Santandrea, F. Atzeni, T. Vago, P. Sarzi-Puttini

  19-23

  01-04-2019

  Published: 1 April 2019

  1303

  PDF: 908

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  Published:

  1162

  PDF: 782

• Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

  G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

  261-267

  Published:

  1170

  PDF: 678

• LABORATORY FINDINGS IN PSORIATIC ARTHRITIS

  L. Punzi, M. Poswiadek, F. Oliviero, A. Lonigro, V. Modesti, R. Ramonda, S. Todesco

  52-55

  Published:

  2113

  PDF: 1322

• Pain patterns in italian patients with osteoarthritis: preliminary results of the MI.D.A. Study (Misurazione del Dolore nell’Artrosi)

  M.A. Cimmino, F. Salaffi, I. Olivieri, F. Trotta, P. Sarzi Puttini, W. Grassi, V. Modena, F.P. Cantatore, S. Bombardieri, S. Adami, L. Punzi, G. Lapadula, Gruppo MI.D.A.

  253-261

  Published:

  2287

  PDF: 6270

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  Published:

  1003

  PDF: 967

• Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco

  12-33

  Published:

  1482

  PDF: 1181

• HAQ-DI Italian version in systemic sclerosis

  G. La Montagna, G. Cuomo, I. Chiarolanza, L. Ruocco, G. Valentini

  112-115

  Published:

  1495

  PDF: 1912

• Endothelin-1 in systemic sclerosis

  M.E. Secchi, A. Sulli, C. Pizzorni, M. Cutolo

  129-134

  Published:

  960

  PDF: 729

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  Published:

  1161

  PDF: 883

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  Published:

  1116

  PDF: 743

• Assessment of circadian rhythm in pain and stiffness in rheumatic diseases according the EMA (Ecologic Momentary Assessment) method: patient compliance with an electronic diary

  F. Salaffi, A. Stancati, R. Procaccini, F. Cioni, W. Grassi

  238-249

  Published:

  1516

  PDF: 1450
• 

  Red cell distribution width is a potential predictor of early relapse in polymyalgia rheumatica

  D. Soddu, D. Sola, M. Bellan, E. Boin, M.G. Cittone, E. Zecca, E. Matino, R. Pedrazzoli, E. Rizzi, A.R. Pedrinelli, S. Tonello, V. Vassia, R. Landi, M. Pirisi, P.P. Sainaghi

  117-121

  03-08-2021

  Published: 3 August 2021

  2730

  PDF: 536